MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NYSESPB |
Shares |
2.41 B |
Market Cap[1] |
$ 643 B |
EBITDA (LTM) |
$ 7.5 B |
P/E (LTM) |
24.728661 |
P/S (LTM) |
7.034373 |
EPS (LTM) |
11.13 |
Johnson & Johnson is a multinational corporation that specializes in healthcare products, medical devices, and pharmaceuticals. Founded in 1886, the company has grown to become one of the largest healthcare companies in the world, with operations in over 60 countries.
The company's products are used by millions of people every day, from baby shampoo and band-aids to prescription drugs and surgical equipment. Some of its most well-known brands include Tylenol, Neutrogena, and Listerine.
Johnson & Johnson is committed to improving the health and well-being of people around the world. The company invests heavily in research and development, with a focus on finding new treatments for diseases such as cancer, Alzheimer's, and HIV/AIDS.
In addition to its healthcare products, Johnson & Johnson is also known for its commitment to corporate social responsibility. The company has a long history of supporting various charitable causes, including disaster relief efforts and global health initiatives.
Overall, is a trusted and respected leader in the healthcare industry, with a strong track record of innovation and social responsibility.
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Aclaris Therapeutics
ACRS
|
$ 5.71 | 7.24 % | $ 700 M | Nasdaq Global Select Market | USA |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX |  Russia |
 |
AbbVie
ABBV
|
$ 261.51 | 1.66 % | $ 463 B | NYSE,SPB | USA |
 |
AbCellera Biologics
ABCL
|
$ 11.09 | 1.84 % | $ 3.31 B | Nasdaq Global Select Market |  Canada |
 |
Agenus
AGEN
|
$ 7.16 | 3.17 % | $ 213 M | Nasdaq Capital Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market |  Britain |
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Abeona Therapeutics
ABEO
|
$ 5.39 | 0.28 % | $ 285 M | Nasdaq Capital Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 33.38 | 0.16 % | $ 1.94 B | Nasdaq Global Select Market,SPB | USA |
 |
Adagene
ADAG
|
$ 3.29 | 2.94 % | $ 194 M | Nasdaq Global Market |  China |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 24.82 | 2.56 % | $ 3.77 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 23.52 | 458.67 % | $ 98.9 M | Nasdaq Global Select Market | USA |
 |
MediWound Ltd.
MDWD
|
$ 13.84 | 5.57 % | $ 377 M | Nasdaq Global Select Market | Israel |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 5.12 | 0.1 % | $ 981 M | Nasdaq Global Select Market | Canada |
 |
ADC Therapeutics SA
ADCT
|
$ 1.11 | 3.76 % | $ 141 M | NYSE |  Schweiz |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
Adial Pharmaceuticals
ADIL
|
$ 4.97 | 1.43 % | $ 3.32 M | Nasdaq Capital Market | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 27.48 | 0.04 % | $ 4.63 B | Nasdaq Global Select Market,SPB | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.22 | 0.05 % | $ 356 K | NYSE American | USA |
 |
ADMA Biologics
ADMA
|
$ 9.15 | 0.16 % | $ 2.18 B | Nasdaq Global Market | USA |
 |
Axcella Health
AXLA
|
- | -16.42 % | $ 249 M | Nasdaq Global Market | USA |
 |
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | USA |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Achieve Life Sciences
ACHV
|
$ 7.28 | 3.12 % | $ 317 M | Nasdaq Capital Market | USA |
 |
Baudax Bio
BXRX
|
- | 0.59 % | $ 63 K | Nasdaq Capital Market | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |
 |
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | USA |
 |
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.98 | 3.01 % | $ 252 M | Nasdaq Global Market | USA |
 |
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | USA |
|
Cerevel Therapeutics Holdings
CERE
|
- | - | $ 7.29 B | Nasdaq Capital Market | USA |
 |
AC Immune SA
ACIU
|
$ 2.67 | 2.6 % | $ 269 M | Nasdaq Global Market | Schweiz |
 |
Alector
ALEC
|
$ 2.22 | 3.74 % | $ 229 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.